Lifecore Biomedical, Inc. LFCR Business Segments
| Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| CDMO | $15.78M-32.9% | $21.75M-15.1% | $23.52M-19.2% | $20.79M-6.8% | $25.61M+8.2% | |
| HA manufacturing | $7.42M-42.6% | $9.36M+34.6% | $12.93M+47.0% | $14.37M+7.2% | $6.95M+7.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Lifecore Biomedical, Inc. break its business down?
- Lifecore Biomedical, Inc. (LFCR) reports revenue by product across 2 parts — CDMO and HA manufacturing. Each is extracted from the segment footnotes and tracked over time.
- Where does Lifecore Biomedical, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Lifecore Biomedical, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
